Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Chinese Physician ; (12): 871-874,880, 2022.
Artículo en Chino | WPRIM | ID: wpr-956233

RESUMEN

Objective:To study the efficacy of transurethral plasmakinetic enucleation and resection of the prostate (TUERP) in the treatment of patients with small and medium-sized benign prostatic hyperplasia (BPH) (<60 ml).Methods:102 clinical cases of BPH (volume <60 ml) in Renmin Hospital of Wuhan University from October 2018 to July 2020 were retrospectively analyzed. All cases were treated with TUERP. The International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), postvoid residual volume (PVR) and prostate specific antigen (PSA) were compared before and after operation. Then the operation efficiency, intraoperative blood loss and postoperative complications incidence rate were analyzed.Results:102 patients with BPH successfully completed the operation. The operation time was 34-69(52.8±8.1)min. The change of hemoglobin concentration during the operation was (10.0±4.9)g/L. The volume of prostate resection was 16.5-42(27.8±5.9)g. The postoperative pathology showed that the prostate was nodular hyperplasia. Among 102 patients, 5 patients had transient stress urinary incontinence (4.90%), 4 patients had capsule perforation (3.93%), and 2 patients had urethral stricture (1.96%). There were significant differences in IPSS, Qmax, PVR and PSA with the comparison of preoperation and postoperation (six months) (all P<0.01). Conclusions:Transurethral plasmakinetic enucleation and resection of the prostate is safe and effective in the treatment of patients with small and medium-sized benign prostatic hyperplasia (<60 ml). It has the characteristics of high resection efficiency, less bleeding, low incidence of complications and exact curative effect.

2.
China Journal of Endoscopy ; (12): 35-38, 2017.
Artículo en Chino | WPRIM | ID: wpr-613607

RESUMEN

Objective To investigate the clinical safety and effect of transurethral plasmakinetic enucleation and resection of prostate combined with mini-incision in the treatment of senior and high-risk benign prostatic hyperplasia (BPH) with bladder stones. Methods Clinical data of 42 patients of senior and high-risk benign prostatic hyperplasia (BPH) with bladder stones was analyzed. All patients were treated with transurethral plasmakinetic enucleation and resection of prostate combined with mini-incision cystofithotomy. Results All operations were successfully performed without deaths. The operative time was 52~86 min, mean (63.90 ± 16.60) min. The blood loss was 45.0~136.0 ml, mean (73.90 ± 21.10) ml. There were no significant differences in the immediate life characteristics, serum K+, serum brain natriuretic peptide and other internal environmental indexes before and after operation. There were no serious complications in perioperation. 3 months after operation, international prostate symptomscore (IPSS), quality of life score (QOL), the maximum flow rate (Qmax) improved significantly compared with preoperation, significantly reduced the post void residual volume (PVR). Conclusion Transurethral plasmakinetic enucleation and resection of prostate combined with mini-incision can be particularly applied to elderly patients with high risk BPH complicated with bladder stones with efficaciously and more safety.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA